| Paul K Pickrell, MD | |
|
12912 Hill Country Blvd, Bldg F Ste 238, Austin, TX 78738-6328 | |
| (512) 732-2929 | |
| (512) 732-2933 |
| Full Name | Paul K Pickrell |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 12912 Hill Country Blvd, Austin, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114935418 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 11711039-1205 (Utah) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | K0997 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Paul K Pickrell, MD 12912 Hill Country Blvd, Bldg F Ste 238, Austin, TX 78738-6328 Ph: (512) 732-2929 | Paul K Pickrell, MD 12912 Hill Country Blvd, Bldg F Ste 238, Austin, TX 78738-6328 Ph: (512) 732-2929 |
News Archive
Danube Pharmaceuticals, Inc. has announced the initiation of a multi-center, randomized, double-blind, placebo controlled Phase II study with DNB-001 in 60 patients with ocular hypertension (elevated intraocular pressure).
Having high levels of anti-Müllerian hormone – a hormone that indicates the size of a woman's ovarian reserve – before the menopause is associated with an increased risk of breast cancer, new research suggests.
We want to spend just a little less, so that we have more money for other purposes. And we want to spend just a little differently, so that we're getting a higher quality, more humane health care system (Jonathan Cohn, 8/30).
Cancer research is too focused on new drug development, while not enough money and effort is being devoted to pursuing important advances in knowledge likely to have the biggest impact on combating the disease in the next few decades, a leading research policy expert says, adding that a major shift in research priorities will be crucial to the ability to cope with the coming wave of cancer cases.
Watson Pharmaceuticals, Inc. has confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its trospium chloride extended-release 60 mg capsules prior to the expiration of a patent owned by Supernus Pharmaceuticals, Inc.
› Verified 8 days ago
Dr. Tatiana B. Jacobson, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5656 Bee Caves Rd. Bldg C Ste. 102, Austin, TX 78746 Phone: 512-323-5465 Fax: 512-327-1390 | |
Preeti Venkatraman, M.B.B.S. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 601 E 15th St, Austin, TX 78701 Phone: 512-324-7000 | |
Pritesh Harish Gandhi, M.D., M.P.H. Rheumatology Medicare: Medicare Enrolled Practice Location: 1101 Camino La Costa, Austin, TX 78752 Phone: 512-684-1832 | |
Dr. Joshua Lane Davis, D.O. Rheumatology Medicare: Medicare Enrolled Practice Location: 1004 W 32nd St Unit 300, Austin, TX 78705 Phone: 512-324-3440 | |
Dr. Analicia Alvarado, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1500 Red River St, Austin, TX 78701 Phone: 512-324-7000 | |
Dr. Grace Marie Grant-jennings, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 7000 North Mopac, Suite # 420, Austin, TX 78731 Phone: 512-482-0045 Fax: 512-476-9892 | |
Dr. Debra Ann Patt, MD, MPH Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6204 Balcones Dr, Austin, TX 78731 Phone: 512-427-9400 Fax: 512-342-2723 |